Publications

2021

Punjani N, Flannigan R, Kang C, Khani F. Quantifying Heterogeneity of Testicular Histopathology in Men with Nonobstructive Azoospermia. J Urol. 2021;206(5):1268-1275.
Huang J, Linares JF, Duran A, Xia W, Saltiel AR, Müller TD, et al. NBR1 is a critical step in the repression of thermogenesis of p62-deficient adipocytes through PPARγ. Nat Commun. 2021;12(1):2876.
Ketas TJ, Chaturbhuj D, Cruz-Portillo VM, Francomano E, Golden E, Chandrasekhar S, et al. Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva. bioRxiv. 2021.
Perez VA, Husain S, Magro CM, Strom MA, Williams KM, Levin LE. A newly described cutaneous reaction at sites of insulin pump use in a child with Type 1 diabetes. Pediatr Dermatol. 2021;38(1):239-241.
Crowe EP, Goel R, Andrews J, Meyer EK, Wong TE, Sloan SR, et al. Survey of newborn direct antiglobulin testing practice in United States and Canadian transfusion services. Transfusion. 2021;61(4):1080-1092.
Carroll KC, Burnham C-, Westblade LF. From canines to humans: Clinical importance of Staphylococcus pseudintermedius. PLoS Pathog. 2021;17(12):e1009961.
Avadhani V, Cohen C, Siddiqui MT, Krasinskas A. A Subset of Intrahepatic Cholangiocarcinomas Express Albumin RNA as Detected by In Situ Hybridization. Appl Immunohistochem Mol Morphol. 2021;29(3):175-179.
Ryman-Tubb T, Lothion-Roy JH, Metzler VM, Harris AE, Robinson BD, Rizvanov AA, et al. Comparative pathology of dog and human prostate cancer. Vet Med Sci. 2021.
Jain RK, Iv WP, Pond GR, Naqvi M, Kim Y, Curran C, et al. Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma. Clin Genitourin Cancer. 2021;19(6):540-546.
Hissong E, Chiu K, Park H, Solomon J, Song W, Jessurun J. Thyroid-Like Cholangiocarcinoma: Histopathological, Immunohistochemical, In-Situ Hybridization and Molecular Studies on an Uncommon Emerging Entity. Int J Surg Pathol. 2021:10668969211013906.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700